BNP Paribas Financial Markets’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Buy
122,540
+12,651
+12% +$122K ﹤0.01% 2886
2026
Q1
$815K Sell
109,889
-3,079
-3% -$32.4K ﹤0.01% 3276
2025
Q4
$1.33M Sell
112,968
-359,958
-76% -$3.88M ﹤0.01% 2905
2025
Q3
$3.65M Buy
472,926
+231,763
+96% +$1.62M ﹤0.01% 2188
2025
Q2
$1.76M Buy
241,163
+207,413
+615% +$1.67M ﹤0.01% 2561
2025
Q1
$320K Sell
33,750
-3,234
-9% -$40.4K ﹤0.01% 3437
2024
Q4
$609K Sell
36,984
-35,979
-49% -$559K ﹤0.01% 3155
2024
Q3
$1.08M Buy
72,963
+38,238
+110% +$598K ﹤0.01% 2453
2024
Q2
$482K Sell
34,725
-51,030
-60% -$723K ﹤0.01% 2686
2024
Q1
$1.35M Sell
85,755
-15,606
-15% -$241K ﹤0.01% 2301
2023
Q4
$1.64M Sell
101,361
-113,442
-53% -$1.86M ﹤0.01% 2090
2023
Q3
$2.64M Buy
214,803
+32,737
+18% +$487K ﹤0.01% 1708
2023
Q2
$2.93M Buy
182,066
+11,789
+7% +$194K ﹤0.01% 1540
2023
Q1
$2.96M Buy
170,277
+109,516
+180% +$1.56M ﹤0.01% 1560
2022
Q4
$561K Buy
+60,761
New +$566K ﹤0.01% 2500
2022
Q3
Sell
-40,146
Closed -$327K 4928
2022
Q2
$327K Buy
40,146
+7,268
+22% +$69.4K ﹤0.01% 2873
2022
Q1
$399K Sell
32,878
-22,747
-41% -$479K ﹤0.01% 2871
2021
Q4
$1.9M Sell
55,625
-63,884
-53% -$2.5M ﹤0.01% 2072
2021
Q3
$5.77M Buy
119,509
+73,978
+162% +$3.42M 0.01% 1221
2021
Q2
$2.06M Buy
45,531
+19,693
+76% +$873K ﹤0.01% 1742
2021
Q1
$1.25M Buy
25,838
+3,768
+17% +$196K ﹤0.01% 2004
2020
Q4
$1.19M Sell
22,070
-4,561
-17% -$206K ﹤0.01% 1910
2020
Q3
$982K Buy
26,631
+17,743
+200% +$660K ﹤0.01% 1822
2020
Q2
$275K Sell
8,888
-32,205
-78% -$892K ﹤0.01% 2363
2020
Q1
$1.13M Buy
41,093
+13,513
+49% +$405K ﹤0.01% 1831
2019
Q4
$807K Buy
27,580
+10,426
+61% +$248K ﹤0.01% 2154
2019
Q3
$328K Buy
17,154
+6,156
+56% +$144K ﹤0.01% 2455
2019
Q2
$241K Sell
10,998
-6,099
-36% -$134K ﹤0.01% 2496
2019
Q1
$350K Buy
17,097
+17,075
+77,614% +$297K ﹤0.01% 2338
2018
Q4
$277 Sell
22
-1,860
-99% -$27.7K ﹤0.01% 4060
2018
Q3
$28.9K Sell
1,882
-222
-11% -$3.07K ﹤0.01% 3260
2018
Q2
$27.6K Sell
2,104
-9,929
-83% -$109K ﹤0.01% 3368
2018
Q1
$98.2K Sell
12,033
-1
-0% -$8 ﹤0.01% 3189
2017
Q4
$107K Buy
12,034
+6,681
+125% +$61.6K ﹤0.01% 3270
2017
Q3
$59.6K Sell
5,353
-423
-7% -$4.12K ﹤0.01% 3056
2017
Q2
$51.8K Buy
5,776
+5,549
+2,444% +$44K ﹤0.01% 3177
2017
Q1
$1.79K Sell
227
-2,614
-92% -$21.3K ﹤0.01% 3562
2016
Q4
$24.3K Sell
2,841
-738
-21% -$6.32K ﹤0.01% 3104
2016
Q3
$29.4K Buy
3,579
+1,523
+74% +$12.8K ﹤0.01% 2684
2016
Q2
$16.5K Buy
+2,056
New +$16.5K ﹤0.01% 2669
2016
Q1
Sell
-10,494
Closed -$82.6K 2936
2015
Q4
$82.6K Sell
10,494
-1,481
-12% -$10.8K ﹤0.01% 2465
2015
Q3
$68.6K Buy
11,975
+7,521
+169% +$46.6K ﹤0.01% 2639
2015
Q2
$24.1K Buy
+4,454
New +$23K ﹤0.01% 2930
2014
Q3
Sell
-1,312
Closed -$4.36K 4215
2014
Q2
$4.36K Sell
1,312
-152
-10% -$505 ﹤0.01% 2655
2014
Q1
$4.85K Sell
1,464
-308
-17% -$1.15K ﹤0.01% 2412
2013
Q4
$6.42K Sell
1,772
-8,788
-83% -$30.5K ﹤0.01% 2935
2013
Q3
$31.7K Sell
10,560
-2,592
-20% -$7.3K ﹤0.01% 2550
2013
Q2
$52.3K Buy
+13,152
New +$50.2K ﹤0.01% 2666

Other funds holding NEO

BNP Paribas Financial Markets's NEO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its NeoGenomics (NEO) stake by 12% in Q2 2026, buying an estimated $122K and bringing the position to 122,540 shares worth $1.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

BNP Paribas Financial Markets first reported a position in NEO in Q2 2013 and has held it in 48 quarters since. The position peaked at $5.77M in Q3 2021. 254 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • BNP Paribas Financial Markets held 122,540 shares of NeoGenomics worth $1.79M as of Q2 2026.
  • BNP Paribas Financial Markets bought 12,651 NeoGenomics shares in Q2 2026, an estimated $122K.
  • NeoGenomics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2886 holding.
  • BNP Paribas Financial Markets first reported a position in NeoGenomics in Q2 2013 and has held it in 48 quarters since.
  • BNP Paribas Financial Markets's NeoGenomics position peaked at $5.77M in Q3 2021.
  • 254 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.